European stocks traded lower on Monday in a combination of concerns, including a profit warning from business software giant SAP, new restrictions on activity in response to COVID-19, and U.S. Excitement negotiations include difficulties.
Stocks Europe 600 SXXP, down 1.4% last week
Decreased by 1.2%.
After SAP warning, German DAX DAX,
Skidded 2.7%. French CAC 40 PX1,
1.2% and UK FTSE 100 UKX,
Lost 0.6%.
Dow Jones Industrial Futures on the Industrial Average YM100,
285 points were stuck. S&P 500 SPX,
Fell 0.5% last week.
Further restrictions on activity were introduced in Europe to combat the second wave of coronavirus. Italy will close bars and restaurants from Monday to 6pm, and cinemas and gyms will close together, while Spain will introduce a curfew at 11pm. The countries of the Northern Hemisphere are facing a “dangerous moment,” said Tedros Adhanam Brebrasius, director general of the World Health Organization.
In a separate interview with CNN on Sunday, House Speaker Nancy Pelosi and White House Chief of Staff Mark Meadows accused each other of moving goalposts in provocative talks.
Investors in Europe are also discussing the post-Brexit trade deal between the European Union and the UK, with a meeting of the European Central Bank this week and the U.S.
Also of note, the USDTRY,
8 The Turkish lira broke, another indicator of the economic crisis facing Turkey.
SAP SAP,
S.A.P.,
Falling 23% – its worst performance since losing 23% on October 23, 1996 – German business software giant revised its 2020 outlook as the effect of the Covid-19 pushed consumer investments into one. And two years. SAP said its 2023 operating margin will be 5 percentage points lower than the previous target.
Teamwear TMV,
Capgemini CAP, creator of remote software, and IT consultant
Left even after SAP’s warning.
Coca-Cola European partners CCEP,
CCEP,
Coca-Cola Amatil rose 1% after offering સી 10.8 billion or .2.52 billion for CCL,
The largest bottlers and distributors of ready-to-drink non-alcoholic and alcoholic beverages and coffee in the Asia Pacific region. Coca-Cola COO,
Temporarily agreed to sell 31% of its stake. Coca-Cola European bottlers said separately that adjusted revenue fell %% in the third quarter.
BAYN BAYN,
The US-headquartered biopharmaceutical company, which specializes in gene therapy, slipped 1% after it said it would pay 4 4 billion for Asclepius Biopharmaceuticals.
.